S. Silbernagl and A. Despopoulos, Atlas de poche de physiologie. 4 e éd. Flammarion Médecine-Sciences, 2008.

E. Marieb and . Anatomie-et-physiologie-humaine, Contribution à l'étude du pouvoir immunomodulateur des bifidobactéries: analyse in vitro et étude ex vivo des mécanismes moléculaires impliqués [Internet]. [cité 2011 oct 6];Available from, MICI%200809.pdf 4. Digestion_L2_Support_du_cours.pdf (Objet application/pdf) [Internet]. [cité 2011 oct 6];Available from Liste des bactéries pathogènes [Internet]. Bioltrop. [cité 2011 oct 11];Available from, 2005.

P. Bourlioux, . Dossier, . Composition, . Et, and . De-la-flore-intestinale-|-institut-danone, Available from: http://www.institutdanone.org/objectif-nutrition/composition-et-roles-de-la-flore-intestinale- mieux-connaitre-son-importance/dossier-composition-et-roles, Internet]. [cité 2011 oct 4]

R. Sartor, Microbial Influences in Inflammatory Bowel Diseases, Gastroenterology, vol.134, issue.2, pp.577-94, 2008.
DOI : 10.1053/j.gastro.2007.11.059

J. Rambaud, J. Buts, G. Corthier, and B. Flourié, Flore microbienne intestinale Physiologie et pathologie digestives, 2004.

M. Hagiage and . La-flore-intestinale-de-l-'équilibre-au-désequilibre, France: Vigot, 1994.

J. Qin, R. Li, J. Raes, M. Arumugam, K. Burgdorf et al., A human gut microbial gene catalogue established by metagenomic sequencing, Nature, vol.13, issue.7285, pp.59-65
DOI : 10.1038/nature08821

URL : https://hal.archives-ouvertes.fr/cea-00908974

L. Edouard, P. M. Bik, E. Bernstein, C. Purdom, E. Dethlefsen et al., Maladies inflammatoires chroniques de l'intestin.Progrès en hépato-gastro entérologie

R. Sartor, Microbial Influences in Inflammatory Bowel Diseases, Gastroenterology, vol.134, issue.2, pp.577-94, 2008.
DOI : 10.1053/j.gastro.2007.11.059

P. Eckburg and D. Relman, The Role of Microbes in Crohn's Disease. Clinical Infectious Diseases, janv, vol.1544, issue.2, pp.256-62, 2007.

M. Li, B. Wang, M. Zhang, M. Rantalainen, S. Wang et al., Symbiotic gut microbes modulate human metabolic phenotypes, Proceedings of the National Academy of Sciences, vol.105, issue.6, pp.2117-2139, 2008.
DOI : 10.1073/pnas.0712038105

V. Mai and P. Draganov, Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health, World Journal of Gastroenterology, vol.15, issue.1, pp.81-86, 2009.
DOI : 10.3748/wjg.15.81

A. Swidsinski, A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-baucke et al., Mucosal flora in inflammatory bowel disease, Gastroenterology, vol.122, issue.1, pp.44-54, 2002.
DOI : 10.1053/gast.2002.30294

P. Harper, E. Lee, M. Kettlewell, M. Bennett, and D. Jewell, Role of the faecal stream in the maintenance of Crohn's colitis. Gut. 1985 mars, pp.279-84

P. Rutgeerts, K. Goboes, M. Peeters, M. Hiele, F. Penninckx et al., Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum, The Lancet, vol.338, issue.8770, pp.771-775, 1991.
DOI : 10.1016/0140-6736(91)90663-A

J. Korzenik, Is Crohn's disease due to defective immunity? Gut, pp.2-5, 2007.

L. Simms, J. Doecke, M. Walsh, N. Huang, E. Fowler et al., Reduced ??-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease, Gut, vol.57, issue.7, pp.903-913, 2008.
DOI : 10.1136/gut.2007.142588

P. Rutgeerts, M. Hiele, K. Geboes, M. Peeters, F. Penninckx et al., Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection, Gastroenterology, vol.108, issue.6, pp.1617-1638, 1995.
DOI : 10.1016/0016-5085(95)90121-3

B. Chassaing and A. Darfeuille-michaud, The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1720-1728, 2011.
DOI : 10.1053/j.gastro.2011.01.054

V. Peltekova, R. Wintle, L. Rubin, C. Amos, Q. Huang et al., Functional variants of OCTN cation transporter genes are associated with Crohn disease, Nature Genetics, vol.36, issue.5, pp.471-476, 2004.
DOI : 10.1038/ng1339

A. Martin, A. Troillard, R. Glorot, A. Justum, and J. Reimund, Place des biothérapies dans la prise en charge des MICI :Etude rétrospective évaluant le profil et le type de prise en charge des patients traités par infliximab (efficacité et tolérance)au CHU de Grenoble de 2000 à 2008. Grenoble; 2009. 39. Les Maladies Inflammatoires Chroniques de l'Intestin (MICI) Aspects immunologiques [Internet]. [cité 2011 déc 12];Available from: http://pharmaweb.univ- lille2.fr/apache2-default, Gastroenterol Clin Biol, vol.40, pp.262-71, 2006.

X. Hébuterne, J. Filippi, A. , R. Schneider, and S. , Nutritional consequences and nutrition therapy in Crohn's disease. Gastroentérologie Clinique et Biologique, pp.235-279, 2009.

X. Hébuterne, A. , and R. , Conséquences nutritionnellesdes maladies inflammatoirescryptogénétiquesde l'intestin. La lettre de l'hepatogastro entérologue, 2003.

J. Filippi, R. Aljaouni, J. Wiroth, X. Hébuterne, and S. Schneider, Nutritional deficiencies in patients with Crohn??s disease in remission, Inflammatory Bowel Diseases, vol.12, issue.3, pp.185-91, 2006.
DOI : 10.1097/01.MIB.0000206541.15963.c3

C. Hartman, R. Eliakim, and R. Shamir, Nutritional status and nutritional therapy in inflammatory bowel diseases, World Journal of Gastroenterology, vol.15, issue.21, pp.2570-2578
DOI : 10.3748/wjg.15.2570

F. Fernandez-banares, A. Abad-lacruz, X. Xiol, J. Gine, C. Dolz et al., Vitamin status in patients with inflammatory bowel disease, Am. J. Gastroenterol, vol.84, issue.7, pp.744-752, 1989.

M. Verway, M. Behr, and J. White, Vitamin D, NOD2, autophagy and Crohn???s disease, Expert Review of Clinical Immunology, vol.6, issue.4, pp.505-513, 2010.
DOI : 10.1586/eci.10.31

F. Ghishan and P. Kiela, Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases, AJP: Gastrointestinal and Liver Physiology, vol.300, issue.2, pp.191-201, 2011.
DOI : 10.1152/ajpgi.00496.2010

P. Scanlan, F. Shanahan, O. Mahony, C. Marchesi, and J. , Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease, Journal of Clinical Microbiology, vol.44, issue.11, pp.3980-3988, 2006.
DOI : 10.1128/JCM.00312-06

C. Manichanh, L. Rigottier-gois, E. Bonnaud, K. Gloux, E. Pelletier et al., Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, vol.55, issue.2, pp.205-216, 2006.
DOI : 10.1136/gut.2005.073817

R. Sartor, Therapeutic correction of bacterial dysbiosis discovered by molecular techniques, Proceedings of the National Academy of Sciences, vol.105, issue.43, pp.16413-16417, 2008.
DOI : 10.1073/pnas.0809363105

H. Sokol, P. Seksik, L. Rigottier-gois, C. Lay, P. Lepage et al., Specificities of the fecal microbiota in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.12, issue.2, pp.106-117, 2006.
DOI : 10.1097/01.MIB.0000200323.38139.c6

G. Mh, H. Cd, and D. Bi, The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique, Journal of Medical Microbiology, vol.35, issue.4, pp.238-281, 1991.

H. Sokol, B. Pigneur, L. Watterlot, O. Lakhdari, L. Bermúdez-humarán et al., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proceedings of the National Academy of Sciences, vol.105, issue.43, pp.16731-16737, 2008.
DOI : 10.1073/pnas.0804812105

URL : https://hal.archives-ouvertes.fr/hal-00652961

A. Darfeuille-michaud, J. Boudeau, P. Bulois, C. Neut, A. Glasser et al., High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn???s disease, Gastroenterology, vol.127, issue.2, pp.412-433, 2004.
DOI : 10.1053/j.gastro.2004.04.061

P. Kozuch, S. Hanauer, F. Baert, G. Van-assche, . Caenepeel et al., Treatment of inflammatory bowel disease: A review of medical therapy The ideal management of Crohn's disease: top down versus step up strategies, a randomizedcontrolled trialAvailable from: http://www.efsa.europa.eu/fr/faqs/faqnutrition.htm 64. OMS | L'Europe met les allégations de santé à l'épreuve [Internet]. OMSAvailable from: http://www.eufic.org/article/fr/nutrition/aliments- fonctionnels/artid/Bacteries-probiotiques-recherches-poursuivent/ 66. Flore intestinale et probiotiques_PRADINES-PAGES.pdf (Objet application/pdf) [Internet], A108. 63. EFSA: FAQ sur les allégations nutritionnelles et de santé [Internet]. [cité 2011 oct 18] Bactéries probiotiques ? les recherches se poursuivent? (EUFIC) [Internet]. [cité 2011 oct 18]Flore%20intestinale%20et%20probiotiques_PRADINES- PAGES.pdf 67. D'Adamo,Kelly. Les probiotiques et le rôle de votre groupe sanguin [Internet]. nutritionk21, pp.354-77, 2006.

P. Seksik, 07 BullMICI -Probiotiques et MICI : faut-il y croire?, 2007.

N. Rousseau, Probiotiques: les bactéries sont-elles réellement nos amies? Health and food, 2005.

F. Guarner, . Président, G. Espagne-)-aamir, and . Khan, Pays Bas) World Gastroenterology Organisation mondiale de Gastroentérologie Recommandation Pratique: Probiotiques et Prébiotiques Probiotiques -Prébiotiques -Symbiotiques (2/2) -Globepharma [Internet]. globepharma. [cité 2011 oct 19];Available from: http://globepharma.over-blog.com/article- probiotiques-prebiotiques-symbiotiques-2-2-63285043.html 73. fiche conseil prébiotiques,probiotiques [Internet]. pharmaciedelepoulle. [cité Invited review: Application of omics tools to understanding probiotic functionality, J. Dairy Sci, vol.7294, issue.10, pp.4753-65, 2008.

F. Yan and D. Polk, Probiotics and immune health, Current Opinion in Gastroenterology, vol.27, issue.6, pp.496-501, 2011.
DOI : 10.1097/MOG.0b013e32834baa4d

. Bifidobacterium-animalis-subsp, lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes, Proceedings of the National Academy of Sciences, pp.18132-18139, 2010.

M. Guslandi, G. Mezzi, M. Sorghi, and P. Testoni, Saccharomyces boulardii in maintenance treatment of Crohn's disease, Digestive Diseases and Sciences, vol.45, issue.7, pp.1462-1466, 2000.
DOI : 10.1023/A:1005588911207

H. Sokol and P. Seksik, Probiotiques et MICI, Hépato Gastro, vol.14, pp.49-54, 2007.

K. Plein and J. Hotz, Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea, a pilot study, Z gastroenterol, issue.31, pp.129-163, 1993.

M. Campieri and F. Rizello, Combination of antibiotic and probiotic treatment is efficacious in prophylaxisof post-operative recurrence of Crohn's disease: a randomised controlled study vs mesalamine, Gastroenterology, vol.118, 2000.

P. Marteau, H. Sokol, X. Dray, and P. Seksik, Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?, Gastroent??rologie Clinique et Biologique, vol.33, pp.228-262, 2009.
DOI : 10.1016/S0399-8320(09)73158-6

URL : https://hal.archives-ouvertes.fr/hal-00816363

I. Chermesh, A. Tamir, R. Reshef, Y. Chowers, A. Suissa et al., Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn???s Disease, Digestive Diseases and Sciences, vol.21, issue.2, pp.385-394, 2007.
DOI : 10.1007/s10620-006-9549-7

C. Prantera, M. Scribano, G. Falasco, A. Andreoli, and C. Luzi, Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG, Gut, vol.51, issue.3, pp.405-414, 2002.
DOI : 10.1136/gut.51.3.405

A. Ledit, B. Duclos, R. Baumann, and J. Reimund, Probiotiques et maladies inflammatoires chroniques intestinales : à la conquête des pochites ? Gastroenterologie clinique et biologique, p.621, 2004.
DOI : 10.1016/s0399-8320(04)95027-0

A. Bousvaros, S. Guandalini, R. Baldassano, C. Botelho, J. Evans et al., A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease, Lactobacillus GG in inducing and maintaining remission of Crohn's disease, pp.5-88833, 2004.

G. Doherty, G. Bennett, A. Cheifetz, and A. Moss, souche Lactobacillus casei DN-114 001 : résultats d'une étude clinique européenne multicentrique en double aveugle Gastroentérologie Clinique et Biologique Supplement 1):A135. 90 Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease, Aliment. Pharmacol. Ther, vol.3331, issue.38, pp.802-811, 2009.

T. Mimura, F. Rizzello, U. Helwig, G. Poggioli, S. Schreiber et al., Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, vol.53, issue.1, pp.108-122, 2004.
DOI : 10.1136/gut.53.1.108

P. Gionchetti, F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi et al., Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial, Gastroenterology, vol.119, issue.2, pp.305-314, 2000.
DOI : 10.1053/gast.2000.9370

B. Rembacken, A. Snelling, P. Hawkey, D. Chalmers, and A. Axon, Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial, The Lancet, vol.354, issue.9179, pp.635-644, 1999.
DOI : 10.1016/S0140-6736(98)06343-0

W. Kruis, P. Fric, J. Pokrotnieks, M. Lukás, B. Fixa et al., Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, vol.53, issue.11, pp.1617-1640, 2004.
DOI : 10.1136/gut.2003.037747

B. Bonaz, . Stress, E. Immunité-denou, J. Collins, W. Jackson et al., De la phisiologie (intégrée) à la pathologie Nouvelles voies de recherche. Gastroentérologie [Internet]. [cité 2011 oct 14];Available from: http://psydoc-fr.broca.inserm.fr/colloques/cr The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice, Gastroenterology, vol.141, issue.609, pp.599-609, 2011.

M. Emami, A. Gholamrezaei, and H. Daneshgar, Hypnotherapy as an Adjuvant for the Management of Inflammatory Bowel Disease: A Case Report, American Journal of Clinical Hypnosis, vol.91, issue.3, pp.255-62, 2009.
DOI : 10.1080/00029157.1997.10403415

C. Service-diététique, Alimentation pauvre en fibres, 2010.

H. Lorenz-meyer, P. Bauer, C. Nicolay, B. Schulz, J. Purrmann et al., Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial, Scandinavian Journal of Gastroenterology, vol.33, issue.1, pp.778-85, 1996.
DOI : 10.3109/00365529609010352

A. Belluzzi, C. Brignola, M. Campieri, A. Pera, S. Boschi et al., Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease, New England Journal of Medicine, vol.334, issue.24, pp.1557-60, 1996.
DOI : 10.1056/NEJM199606133342401

S. Lecleire, A. Hassan, M. Antonietti, G. Marion-letellier, G. Savoye et al., La glutamine associée à l'arginine diminue l'inflammation intestinale ex vivo chez des patients atteints de maladie de Crohn colique en poussée, 2008.

E. Aghdassi, B. Wendland, A. Steinhart, S. Wolman, K. Jeejeebhoy et al., Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial, Am. J. Gastroenterol, vol.98, issue.2, pp.348-53, 2003.

. Eurekasanté-l, Available from: http://www.eurekasante.fr/ 110. Homeophyto.com | Stress et troubles anxieux [Internet]. homeophyto.com le magazine de l'homeopathie et de la phytotherapie, 2011.

. Magnésium, 2010 juill [cité 2011 oct 14];Available from: http://www.passeportsante.net/fr/Solutions/PlantesSupplements/Fiche.aspx?doc=magnesium_ ps

E. Poleszak, B. Szewczyk, E. Kedzierska, P. Wla?, A. Pilc et al., Antidepressant- and anxiolytic-like activity of magnesium in mice, Pharmacology Biochemistry and Behavior, vol.78, issue.1, pp.7-12, 2004.
DOI : 10.1016/j.pbb.2004.01.006

N. Whittle, L. Li, W. Chen, J. Yang, S. Sartori et al., Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior, Amino Acids, vol.8, issue.4, pp.1231-1279, 2011.
DOI : 10.1007/s00726-010-0758-1

S. Sartori, N. Whittle, A. Hetzenauer, and N. Singewald, Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment, Neuropharmacology, vol.62, issue.1, 21835188.
DOI : 10.1016/j.neuropharm.2011.07.027

F. Guerrero-romero, C. Bermudez-peña, and M. Rodríguez-morán, Severe hypomagnesemia and low-grade inflammation in metabolic syndrome, Magnes Res. 2011 juin, vol.124, issue.2, pp.45-53

B. Pokra?niewicz, Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action, Pharmacol Rep, vol.60, issue.5, pp.588-597, 2008.

D. Souza, M. Walker, A. Robinson, P. Bolland, and K. , for the Relief of Anxiety-Related Premenstrual Symptoms: A Randomized, Double-Blind, Crossover Study, Journal of Women's Health & Gender-Based Medicine, vol.9, issue.2, pp.131-140, 2000.
DOI : 10.1089/152460900318623

. Synthèse, Available from: http://www.hassante.fr/portail/jcms/c_815923/magne-b6-uvimag-b6-magnesium-vitamine-b6-synthese-d- avis 120, Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, 2008.

M. Lafourcade, T. Larrieu, S. Mato, A. Duffaud, M. Sepers et al., Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions, Nature Neuroscience, vol.433, issue.3, pp.345-50, 2011.
DOI : 10.1126/science.1120972

URL : https://hal.archives-ouvertes.fr/hal-00612705